Table 2.
No. | Compound | KA (μM) * | |||
---|---|---|---|---|---|
hCA I a | hCA II a | PhaCA b | CpsCA b | ||
1 | l-His | 0.03 | 10.9 | 12.6 | 47.5 |
2 | d-His | 0.09 | 43 | 9.41 | 35.9 |
3 | l-Phe | 0.07 | 0.013 | 15.8 | >100 |
4 | d-Phe | 86 | 0.035 | 3.19 | 15.4 |
5 | l-DOPA | 3.1 | 11.4 | 1.08 | 4.79 |
6 | d-DOPA | 4.9 | 7.8 | 0.72 | 11.2 |
7 | l-Trp | 44 | 27 | 7.12 | 21.3 |
8 | d-Trp | 41 | 12 | 13.9 | 36.8 |
9 | l-Tyr | 0.02 | 0.011 | 1.02 | 19.5 |
10 | d-Tyr | 0.04 | 0.013 | 7.35 | 18.4 |
11 | 4-H2N-l-Phe | 0.24 | 0.15 | 3.27 | 17.2 |
12 | Histamine | 2.1 | 125 | 6.48 | 20.6 |
13 | Dopamine | 13.5 | 9.2 | 8.70 | 32.1 |
14 | Serotonin | 45 | 50 | 9.05 | 34.8 |
15 | 2-Pyridyl-methylamine | 26 | 34 | 2.39 | 21.5 |
16 | 2-(2-Aminoethyl)pyridine | 13 | 15 | 18.7 | 38.2 |
17 | 1-(2-Aminoethyl)-piperazine | 7.4 | 2.3 | 15.1 | 33.0 |
18 | 4-(2-Aminoethyl)-morpholine | 0.14 | 0.19 | 10.1 | 34.3 |
19 | l-Adrenaline | 0.09 | 96.0 | 17.5 | 79.8 |
20 | l-Asn | 11.3 | >100 | 9.80 | 27.9 |
21 | l-Asp | 5.20 | >100 | 9.85 | 27.3 |
22 | l-Glu | 6.43 | >100 | 9.01 | 24.4 |
23 | d-Glu | 10.7 | >100 | 4.72 | 12.0 |
24 | l-Gln | >100 | >50 | 32.4 | >100 |